UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000016038
Receipt No. R000018643
Official scientific title of the study MicroRNA expression analysis in patients with IBD
Date of disclosure of the study information 2014/12/23
Last modified on 2018/12/26 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study MicroRNA expression analysis in patients with IBD
Title of the study (Brief title) MicroRNA expression analysis in patients with IBD
Region
Japan

Condition
Condition Inflammatory bowel disease (Ulcerative colitis, Crohn disease)
Classification by specialty
Gastroenterology Gastrointestinal surgery
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 The aim of this study is to determine whether microRNA expression was altered in patients with inflammatory bowel disease.
Basic objectives2 Others
Basic objectives -Others Pathologic grasp
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes Functions and profiles of microRNA in IBD become clear.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Maneuver
Interventions/Control_1 Endoscopic biopsy
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria The IBD patient who planned endoscopy and biopsy.
The patient who agreed with this study.
Key exclusion criteria The patient who did not agree with this study.
The patient who cannot perform biopsy.
Target sample size 100

Research contact person
Name of lead principal investigator Hideaki Kimura
Organization Yokohama City University Medical Center
Division name Inflammatory Bowel Disease Center
Address 4-57, Urafune-cho, Minami-ku, Yokohama JAPAN
TEL 045-261-5656
Email hkim@yokohama-cu.ac.jp

Public contact
Name of contact person Hideaki Kimura
Organization Yokohama City University Medical Center
Division name Inflammatory Bowel Disease Center
Address 4-57, Urafune-cho, Minami-ku, Yokohama JAPAN
TEL 045-261-5656
Homepage URL
Email hkim@yokohama-cu.ac.jp

Sponsor
Institute Yokohama City University Medical Center
Institute
Department

Funding Source
Organization Yokohama City University Medical Center
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor The institute of medical science
The university of Tokyo
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 横浜市立大学附属市民総合医療センター(神奈川県)
東京大学医科学研究所(東京都)

Other administrative information
Date of disclosure of the study information
2014 Year 12 Month 23 Day

Progress
Recruitment status Completed
Date of protocol fixation
2011 Year 12 Month 05 Day
Anticipated trial start date
2011 Year 12 Month 05 Day
Last follow-up date
2017 Year 04 Month 18 Day
Date of closure to data entry
2017 Year 04 Month 18 Day
Date trial data considered complete
2017 Year 04 Month 18 Day
Date analysis concluded
2017 Year 04 Month 18 Day

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results Significant alteration in miRNA expression
in line with inflammatory bowel disease was evident in the mucosa from the pouchitis patients. Interleukin 17 receptor A may be involved in the pathogenesis of pouchitis through the downregulation of microRNA 192.
Other related information Inoue E, Hata K, Kimura H, Yamaguchi K, Nojima M, Endo I, Shinozaki M. Altered expression of microRNAs in patients with pouchitis after restorative proctocolectomy. Surg Today. 2017 Dec;47(12):1484-1491.

Management information
Registered date
2014 Year 12 Month 23 Day
Last modified on
2018 Year 12 Month 26 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018643